LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair …
Over the last 12 months, insiders at LifeMD, Inc. have bought $14,790 and sold $0 worth of LifeMD, Inc. stock.
On average, over the past 5 years, insiders at LifeMD, Inc. have bought $884,695 and sold $401,000 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Galluppi Stefan (Chief Innovation Officer) — $14,790.
The last purchase of 3,000 shares for transaction amount of $14,790 was made by Galluppi Stefan (Chief Innovation Officer) on 2024‑09‑11.
2024-09-11 | Chief Innovation Officer | 3,000 0.0069% | $4.93 | $14,790 | +6.09% | |||
2023-08-31 | director | 60,000 0.1695% | $3.93 | $235,800 | +84.46% | |||
2023-08-30 | director | 40,000 0.1084% | $3.76 | $150,400 | +83.85% | |||
2023-08-29 | director | 32,072 0.0871% | $3.58 | $114,818 | +93.34% | |||
2023-06-14 | director | 3,945 0.0123% | $2.94 | $11,580 | +127.52% | |||
2023-06-14 | Chief Acquisition Officer | 10,712 0.0331% | $2.92 | $31,279 | +127.52% | |||
2023-06-13 | director | 49,465 0.1422% | $2.64 | $130,375 | +133.45% | |||
2023-06-13 | General Counsel & CCO | 11,500 0.0326% | $2.60 | $29,900 | +133.45% | |||
2023-06-07 | director | 24,500 0.0768% | $2.19 | $53,547 | +204.55% | |||
2023-06-06 | director | 129,117 0.4074% | $2.18 | $281,398 | +205.96% | |||
2023-06-05 | director | 10,383 0.0325% | $2.17 | $22,480 | +205.96% | |||
2023-05-26 | Chief Operating Officer | 30,000 0.0951% | $2.19 | $65,706 | +194.04% | |||
2023-05-23 | CEO | 32,336 0.0992% | $2.06 | $66,612 | +200.94% | |||
2023-05-23 | Chief Innovation Officer | 4,608 0.0149% | $2.17 | $9,999 | +200.94% | |||
2023-05-22 | CEO | 17,664 0.0555% | $2.15 | $38,013 | +193.98% | |||
2022-05-18 | 50,000 0.1628% | $2.14 | $106,800 | -2.82% | ||||
2022-03-14 | General Counsel & CCO | 5,000 0.0165% | $3.14 | $15,700 | -29.45% | |||
2022-03-10 | 2,000 0.0062% | $3.28 | $6,560 | -36.15% | ||||
2021-12-07 | director | 25,000 0.0931% | $4.54 | $113,500 | -44.86% | |||
2021-12-03 | director | 110,000 0.406% | $3.91 | $430,100 | -36.27% |
Galluppi Stefan | Chief Innovation Officer | 45449 0.1055% | $5.05 | 6 | 1 | +14.28% |
Schreiber Justin | CEO | 2844620 6.6048% | $5.05 | 28 | 0 | +85.91% |
Walters Happy David | 2148956 4.9896% | $5.05 | 14 | 0 | +31.27% | |
Velge Bertrand | director | 349482 0.8114% | $5.05 | 12 | 0 | +129.24% |
BHATIA NAVEEN | 246349 0.572% | $5.05 | 3 | 0 | <0.0001% |
Divisadero Street Capital Management Lp | $17.41M | 4 | 1.69M | -8.31% | -$1.58M | 4.09 | |
Invesco | $11.98M | 2.76 | 1.17M | +36.93% | +$3.23M | <0.01 | |
The Vanguard Group | $11.88M | 2.73 | 1.16M | +12.54% | +$1.32M | <0.0001 | |
ROYCE & ASSOCIATES INC | $8.24M | 1.9 | 801,595 | -3.73% | -$318,998.70 | 0.07 | |
Connor Clark & Lunn Investment Management Ltd | $6.13M | 1.41 | 595,907 | +292.97% | +$4.57M | 0.01 |